California Governor Gavin Newsom announced on Saturday a 10-year partnership with nonprofit drug company Civica Rx to manufacture the state’s own supply of insulin. Part of the state’s new CalRx program, the move is only the first step in California’s ambitious plan to produce more affordable generic prescription drugs — like overdose reversal medication naloxone — and make them available on the national market. We’ll talk about CalRx and how it could help address the nation’s drug affordability crisis.
Affordable California-Branded Insulin to Enter National Market
(George Frey via Getty Images)
Guests:
Angela Hart, senior correspondent covering health care politics and policy in California and the West, Kaiser Health News and California Healthline
Kevin Wren, patient advocate and volunteer, California #insulin4all
Robin Feldman, professor and director of the Center for Innovation, UC Law; author of “Drugs, Money, and Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices”
Sponsored